Yearly Archives: 2013

Drug Patent Expirations for February 2013

Tradename Applicant Generic Name Patent Number Patent Expiration
IMODIUM MULTI-SYMPTOM RELIEF Mcneil loperamide hydrochloride; simethicone 5,489,436 Feb 6, 2013
IMODIUM A-D EZ CHEWS Mcneil loperamide hydrochloride 5,489,436 Feb 6, 2013
COLESTID Pharmacia And Upjohn colestipol hydrochloride 5,490,987 Feb 13, 2013
ZOLOFT Pfizer sertraline hydrochloride 5,248,699*PED Feb 13, 2013
ARRANON Smithkline Beecham nelarabine 5,492,897 Feb 20, 2013
ARRANON Smithkline Beecham nelarabine 5,747,472 Feb 20, 2013
ARRANON Smithkline Beecham nelarabine 5,821,236 Feb 20, 2013
ABRAXANE Abraxis Bioscience paclitaxel 6,753,006 Feb 22, 2013
ABRAXANE Abraxis Bioscience paclitaxel 6,096,331 Feb 22, 2013
ABRAXANE Abraxis Bioscience paclitaxel 5,439,686 Feb 22, 2013
ABRAXANE Abraxis Bioscience paclitaxel 6,749,868 Feb 22, 2013
ABRAXANE Abraxis Bioscience paclitaxel 6,537,579 Feb 22, 2013
ABRAXANE Abraxis Bioscience paclitaxel 6,506,405 Feb 22, 2013
DATSCAN Ge Hlthcare Inc ioflupane i-123 5,310,912 Feb 25, 2013
PREZISTA Janssen Prods darunavir ethanolate 6,335,460*PED Feb 25, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.